Real-world MS relapse rate is low for dimethyl fumarate

NATIONAL HARBOR, MD. – A real-world comparison of relapse rates in multiple sclerosis (MS) patients for five disease-modifying therapies (DMTs) found the largest decrease for delayed-release dimethyl...
Source: Family Practice News - Category: Primary Care Source Type: news